Skip to main content

Animations

MJFF Publications

2821 - 2830 of 8818 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2021
  • 2021
  • 2021
  • 2021
  • 2022
  • 2022
  • 2021
  • Summary Details
    OPEN
    Title: Long-term exposure to low-level particulate air pollution and Parkinson's disease diagnosis - A Finnish register-based study
    Journal Name: Environmental Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.envres.2023.115944
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2023.106343
    Citation Count: 8
  • Summary Details
    OPEN
    Title: A role for the subthalamic nucleus in aversive learning
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2023.113328
    Citation Count: 12
  • Summary Details
    RESTRICTED
    Title: RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson’s disease
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00088-6
    Citation Count: 62
  • Summary Details
    OPEN
    Title: Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson’s disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00042-6
    Citation Count: 47
  • Summary Details
    RESTRICTED
    Title: Dysregulated miRNAs mark Parkinson’s disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00046-2
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer’s disease
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00071-1
    Citation Count: 43
  • Summary Details
    RESTRICTED
    Title: Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41594-022-00837-0
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Deep brain stimulation for obsessive–compulsive disorder: a crisis of access
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-022-01879-z
    Citation Count: 67
  • Summary Details
    RESTRICTED
    Title: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-021-01455-x
    Citation Count: 103
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.